2018 US HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
This DataPack presents the US test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:
- Hospitals
- Commercial/Private Labs
- Blood Banks
- Public Health Labs
- Physician Offices
The DataPack provides sales and market Share estimates for major suppliers of AIDS testing including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics, and Roche.
List of Tables
Table 1. Major Companies Developing or Marketing AIDS Tests
Table 2. USA: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
Table 3. USA: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4. USA: Western Blot Tests Volume and Sales Forecast by Market Segment
Table 5. USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6. USA: AIDS Diagnostics Market by Major Supplier
Table 7. USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Major Companies Developing or Marketing AIDS Tests
USA: HIV or HIV-1/2/Combo Test Volume and Sales Forecast
by Market Segment
USA: HIV Ag Test Volume and Sales Forecast by Market Segment
USA: Western Blot/Other Confirmatory Tests Volume
and Sales Forecast By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares
of Major Suppliers
Global Oncolytic Virus Therapy Market Size study, by Type (Oncolytic Wild Type Viruses, Genetically Engineered Oncolytic Viruses), by Application (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer) and Regional Forecasts 2018-2025
Global Oncolytic Virus Therapy Market to reach USD XX million by 2025.Global Oncolytic Virus Therapy Market valued approximately USD XX million in 2017 is anticipated to grow with a healthy
View ReportGlobal CNS Therapeutics Market Size study, by Type (Neurodegenerative, Mood Disorders, Schizophrenia, Autism, Depression), by Application (Hospital Use, Clinic Use, Household, Others) and Regional Forecasts 2018-2025
Global CNS Therapeutics Market to reach USD 130 billion by 2025.Global CNS Therapeutics Market valued approximately USD 82.3 billion in 2017 is anticipated to grow with a healthy growth rate
View Report2018 USA Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts--Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs
Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis
View Report2018 US HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts--Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs
Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500. This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and
View ReportYour are not allow to send sample request
Fill The Form For Sample Request